Company: ELV
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001156039-25-000046
Chunk: 87

Company: Elevance Health, Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 87
---
 directors, executive officers and holders of more than 10% of our common stock to file with the SEC reports of ownership and changes in ownership. Based on a review of such reports and written representations from our reporting persons, we believe that all such reports were timely filed, except for one Form 4 for Mr. Blair Todt, a former executive officer, reporting the withholding of 1,127 shares of common stock upon the vesting of previously granted PSUs to cover his tax liability, which was filed late due to an administrative error.

#### 2025 Proxy Statement77
Information on Voting and the Annual Meeting

#### Voting and Meeting Information

#### Record Date and Quorum
At the close of business on March 17, 2025, the record date for the Annual Meeting, there were 226,386,925 shares of our common stock outstanding and entitled to vote at the Annual Meeting.

In order for business to be conducted at the Annual Meeting, 25% of the votes entitled to be cast on a matter, represented in person or by proxy, must be present.

#### Vote Required
You have one vote for each share held. Shares of our common stock represented by properly executed proxies will be voted at the Annual Meeting in accordance with the choices indicated on the proxy. Abstentions on a specific proposal will be counted as present for purposes of determining whether a quorum is present at the Annual Meeting.

If you provide specific voting instructions, your shares will be voted as you instruct. If you sign, date and return your proxy card, but do not provide instructions, your shares will be voted:

• FOR Proposal 1 — election of each director nominee

• FOR Proposal 2 — advisory vote to approve the compensation of our Named Executive Officers

• FOR Proposal 3 — ratification of the appointment of our independent registered public accounting firm for 2025

• AGAINST Proposal 4 — shareholderproposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts

Each proposal will be approved if it receives more votes “for” than “against.” For the election of directors, the number of shares voted “for” a director nominee must exceed the number of shares voted “against” such nominee. If any nominee for director is unable or unwilling to accept the nomination or election, then the proxies may nominate such other person as director as they may determine in their discretion, in which event the shares will be voted for such other person. Alternatively, the Board may decide to reduce the number of directors constituting the full